To the Editor In an Invited Commentary¹ accompanying our Original Investigation,² both published in a recent issue of JAMA Internal Medicine, Villines and Shaw¹ emphasize findings that they feel support the National Institute for Health and Care Excellence (NICE) decision to recommend coronary computed tomographic angiography (CCTA) as the initial test for patients with suspected coronary artery disease (CAD). Their argument focuses on the statistically significant reduction in myocardial infarction (MI). We disagree with their interpretation and conclusion.

中文翻译：

---

反对NICE决定

要编辑在特邀解说¹伴随我们的原反倾销调查，²都发表在近期出版的问题JAMA内科，Villines和Shaw ¹强调结果，他们觉得支持健康与保健卓越（NICE）决定建议冠状动脉研究所计算机断层血管造影（CCTA）作为可疑冠状动脉疾病（CAD）患者的初始测试。他们的论点集中在心肌梗塞（MI）的统计学显着降低上。我们不同意他们的解释和结论。